Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Lisa Brown

Physician Assistant, Surgical Bay City, MI Physician Assistant

NPI 1962552273 CMS profile 10833018

4497 Sheffield Pl, Bay City, MI 48706

Open in the dashboard

General payments

$9,727

523 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lisa Brown of Bay City, MI is reported in the CMS Open Payments database as having received $9,727 across 523 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,665 116
2024 General $1,969 111
2023 General $1,694 93
2022 General $1,845 102
2021 General $1,555 101

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lisa Brown
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Lisa Brown were reported at $2,665. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Lisa Brown Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,555 $111 $36–$285 $132
2022 $1,845 $126 $44–$350 $149
2023 $1,694 $137 $47–$355 $160
2024 $1,969 $146 $49–$384 $164
2025 $2,665 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $1,483 108 payments
  2. Janssen Biotech, Inc. $1,222 75 payments
  3. Sun Pharmaceutical Industries Inc. $1,045 58 payments
  4. Novartis Pharmaceuticals Corporation $891 53 payments
  5. Genzyme Corporation $705 30 payments
  6. Lilly USA, LLC $598 28 payments
  7. UCB, Inc. $470 11 payments
  8. Regeneron Healthcare Solutions, Inc. $467 20 payments
  9. Amgen Inc. $457 19 payments
  10. E.R. Squibb & Sons, L.L.C. $415 32 payments
  11. Other $1,975 89 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $9,340 518 payments
  2. Education $388 5 payments
Products named General payments · program years 2021–2025
  1. DUPIXENT $1,164 42 payments
  2. TREMFYA $893 46 payments
  3. ILUMYA $887 47 payments
  4. RINVOQ $664 40 payments
  5. Otezla $457 19 payments
  6. TALTZ $451 21 payments
  7. COSENTYX $447 30 payments
  8. SKYRIZI $419 45 payments
  9. Bimzelx $392 7 payments
  10. SOTYKTU $385 30 payments
  11. Other $5,580 331 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 25 drugs

Part D claims

1,001

Median for Physician Assistant: 241

Drug cost

$492,604

Median for Physician Assistant: $4,110

Branded share of claims

12.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cosentyx Sensoready (2 Pens) Secukinumab Brand 36 $270,835
Dupixent Pen Dupilumab Brand 32 $121,634
Humira(Cf) Pen Adalimumab Brand 12 $80,028
Fluorouracil Generic 123 $7,480
Ketoconazole Generic 159 $2,872
Metronidazole Generic 21 $1,919
Clobetasol Propionate Generic 28 $1,824
Betamethasone Dipropionate Generic 17 $898
Triamcinolone Acetonide Generic 100 $680
Mupirocin Generic 73 $604

The 10 drugs with the highest cost, of 25 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$99,021

Of which drugs: $3,159

Medicare patients

393

Average age 72

Services billed

2,374

228 women, 165 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 48%
Ischemic heart disease 28%
Diabetes 23%
Chronic kidney disease 18%
Depression 17%
Atrial fibrillation 15%
Cancer 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 43 70 $52

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 25 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
TREMFYA
  • Janssen Biotech, Inc. $312
$312 — —
DUPIXENT
  • GENZYME CORPORATION $168
  • Regeneron Healthcare Solutions, Inc. $89
$257 32 —
ILUMYA
  • Sun Pharmaceutical Industries Inc. $179
$179 — —
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $165
$165 — —
RINVOQ
  • AbbVie, Inc. $157
$157 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 25 in the dashboard with a free account

Records

523 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Surgical in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record